Thelma S Angeles

Title: **Thelma S. Angeles: Pioneering Cancer Treatment Innovations**

Introduction

Thelma S. Angeles, an accomplished inventor based in West Chester, PA, has made significant contributions to the field of cancer treatment. With a focus on innovative therapeutics, her work has the potential to revolutionize treatment options for various cancers.

Latest Patents

Thelma holds a patent for "Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents." This patent describes the use of a specific compound, either alone or in combination with other therapeutically active agents, to target cancers where AXL or c-Met are over-expressed. The application opens new avenues for treating both solid and hematological cancers, showcasing the impactful nature of her research.

Career Highlights

Currently, Thelma is associated with Ignyta, Inc., a company known for its focus on developing targeted therapies for cancer treatment. Her role in the organization has been instrumental in advancing research and development of innovative cancer treatment solutions.

Collaborations

During her career, Thelma has had the opportunity to collaborate with talented professionals, including Mark A. Ator and Mangeng M. Cheng. These collaborations are vital for fostering innovation, allowing for the exchange of ideas and expertise necessary to push the boundaries of cancer treatment.

Conclusion

Thelma S. Angeles represents the spirit of innovation in the medical field, particularly in the fight against cancer. Her patent and collaborations highlight her commitment to improving patient outcomes through groundbreaking research. As an inventor, she continues to inspire the next generation of scientists and researchers in the pursuit of effective treatments for challenging diseases.